跳至主要内容
临床试验/CTRI/2021/09/036242
CTRI/2021/09/036242尚未招募未知

A qualitative evaluation of procalcitonin (PCT), Creactive protein (CRP) and interleukin-6 (IL-6) for prognosis of sepsis & septic shock.

Dr B L Kapur Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients admitted in Medical ICU with a suspected diagnosis of Sepsis and Septic Shock, with likely stay >72 hours.

排除标准

  • 1.Patients undergoing any emergency surgery.
  • 2. Patients with a diagnosis of cancer or undergoing therapy for cancer.
  • 3. Pregnant patients
  • 4. Extremely critical patients: Refractory shock, Severe refractory metabolic acidosis
  • (pH <7.0), persistent hypoxemia (PaO2 ( <50 mm Hg), Multiorgan failure on presentation (3
  • or more organ failures on presentation), APACHE II >35, SOFA >20.

研究者

发起方
Dr B L Kapur Memorial Hospital

相似试验